GeneDx Holdings annual capital expenditures (capex)
2019
2020
2021
2022
2023
2024
2025
GeneDx Holdings Capital Expenditures (CapEx) Growth & History (WGS)
GeneDx Holdings's capital expenditures (capex) was $19.0M for fiscal 2025.
View full GeneDx Holdings company overviewGeneDx Holdings annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $19.0M | $13.5M | +246.33% |
| 2024 | 2024-12-31 | $5.5M | $241,000 | +4.59% |
| 2023 | 2023-12-31 | $5.3M | −$1.9M | −26.63% |
| 2022 | 2022-12-31 | $7.2M | −$2.2M | −23.87% |
| 2021 | 2021-12-31 | $9.4M | −$14.7M | −60.99% |
| 2020 | 2020-12-31 | $24.1M | $12.2M | +102.08% |
| 2019 | 2019-12-31 | $11.9M | — | — |
GeneDx Holdings quarterly capital expenditures (capex)
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $10.1M | $7.7M | +326.93% |
| Q1 2026 | 2026-03-31 | $6.5M | $324,000 | +5.29% |
| Q4 2025 | 2025-12-31 | $4.3M | $1.3M | +42.52% |
| Q3 2025 | 2025-09-30 | $6.2M | $5.5M | +855.42% |
| Q2 2025 | 2025-06-30 | $2.4M | $1.0M | +75.22% |
| Q1 2025 | 2025-03-31 | $6.1M | $5.7M | +1283.52% |
| Q4 2024 | 2024-12-31 | $3.0M | $674,000 | +28.37% |
| Q3 2024 | 2024-09-30 | $646,000 | $534,000 | +476.79% |
| Q2 2024 | 2024-06-30 | $1.4M | −$1.4M | −51.05% |
| Q1 2024 | 2024-03-31 | $443,000 | $443,000 | — |
| Q4 2023 | 2023-12-31 | $2.4M | $210,000 | +9.70% |
| Q3 2023 | 2023-09-30 | $112,000 | −$2.1M | −95.00% |
| Q2 2023 | 2023-06-30 | $2.8M | $1.4M | +101.61% |
| Q1 2023 | 2023-03-31 | $0 | −$1.4M | — |
| Q4 2022 | 2022-12-31 | $2.2M | −$2.9M | −57.16% |
| Q3 2022 | 2022-09-30 | $2.2M | $1.2M | +118.95% |
| Q2 2022 | 2022-06-30 | $1.4M | $125,000 | +10.04% |
| Q1 2022 | 2022-03-31 | $1.4M | −$697,000 | −33.59% |
| Q4 2021 | 2021-12-31 | $5.1M | — | — |
| Q3 2021 | 2021-09-30 | $1.0M | — | — |
| Q2 2021 | 2021-06-30 | $1.2M | — | — |
| Q1 2021 | 2021-03-31 | $2.1M | — | — |
GeneDx Holdings capital expenditures (capex) trends
Over the last five fiscal years, GeneDx Holdings's capital expenditures (capex) decreased from $24.1M to $19.0M, a change of −$5.1M. The latest reported quarter, Q2 2026, shows $10.1M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GeneDx Holdings source filings ↗